Your browser doesn't support javascript.
Virulence and pathogenesis of SARS-CoV-2 infection in rhesus macaques: A nonhuman primate model of COVID-19 progression.
Zheng, Huiwen; Li, Heng; Guo, Lei; Liang, Yan; Li, Jing; Wang, Xi; Hu, Yunguang; Wang, Lichun; Liao, Yun; Yang, Fengmei; Li, Yanyan; Fan, Shengtao; Li, Dandan; Cui, Pingfang; Wang, Qingling; Shi, Haijing; Chen, Yanli; Yang, Zening; Yang, Jinling; Shen, Dong; Cun, Wei; Zhou, Xiaofang; Dong, Xingqi; Wang, Yunchuan; Chen, Yong; Dai, Qing; Jin, Weihua; He, Zhanlong; Li, Qihan; Liu, Longding.
  • Zheng H; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Li H; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Guo L; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Liang Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Li J; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Wang X; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Hu Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Wang L; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Liao Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Yang F; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Li Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Fan S; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Li D; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Cui P; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Wang Q; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Shi H; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Chen Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Yang Z; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Yang J; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Shen D; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Cun W; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Zhou X; Yunnan Provincial Center for Disease Control and Prevention, Kunming, Yunnan Province, People's Republic of China.
  • Dong X; Yunnan Provincial Infectious Disease Hospital, Kunming, Yunnan Province, People's Republic of China.
  • Wang Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Chen Y; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Dai Q; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Jin W; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • He Z; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Li Q; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
  • Liu L; Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Kunming, Yunnan Province, People's Republic of China.
PLoS Pathog ; 16(11): e1008949, 2020 11.
Article in English | MEDLINE | ID: covidwho-922716
ABSTRACT
The COVID-19 has emerged as an epidemic, causing severe pneumonia with a high infection rate globally. To better understand the pathogenesis caused by SARS-CoV-2, we developed a rhesus macaque model to mimic natural infection via the nasal route, resulting in the SARS-CoV-2 virus shedding in the nose and stool up to 27 days. Importantly, we observed the pathological progression of marked interstitial pneumonia in the infected animals on 5-7 dpi, with virus dissemination widely occurring in the lower respiratory tract and lymph nodes, and viral RNA was consistently detected from 5 to 21 dpi. During the infection period, the kinetics response of T cells was revealed to contribute to COVID-19 progression. Our findings implied that the antiviral response of T cells was suppressed after 3 days post infection, which might be related to increases in the Treg cell population in PBMCs. Moreover, two waves of the enhanced production of cytokines (TGF-α, IL-4, IL-6, GM-CSF, IL-10, IL-15, IL-1ß), chemokines (MCP-1/CCL2, IL-8/CXCL8, and MIP-1ß/CCL4) were detected in lung tissue. Our data collected from this model suggested that T cell response and cytokine/chemokine changes in lung should be considered as evaluation parameters for COVID-19 treatment and vaccine development, besides of observation of virus shedding and pathological analysis.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Animals Language: English Journal: PLoS Pathog Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Animals Language: English Journal: PLoS Pathog Year: 2020 Document Type: Article